Biohaven Pharmaceutical Holding Company Ltd.
Equities
BHVN
VGG111961055
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.46 USD | +5.56% | -14.38% | -73.40% |
06:02pm | Biohaven Shares Rise After Closing of Public Offering, Disclosure of Stock Purchase by CEO | MT |
04:22pm | UBS Adjusts Biohaven Price Target to $60 From $59, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-73.40% | 541M | |
+3.57% | 42.11B | |
+48.83% | 40.08B | |
+8.70% | 40B | |
-10.82% | 26.87B | |
+8.46% | 24.58B | |
-23.29% | 18.44B | |
+1.92% | 11.94B | |
+34.33% | 11.66B | |
+7.79% | 11.01B |
- Stock Market
- Equities
- BHVN Stock
- News Biohaven Pharmaceutical Holding Company Ltd.
- Cantor Fitzgerald Downgrades Biohaven Pharmaceutical to Neutral From Overweight, Lowers PT to $162 From $182